MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 26 filers reported holding MOLECULIN BIOTECH INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,036,853 | $1,099,064 | 0.41% |
| JMAC ENTERPRISES LLC | 13,132 | $13,920 | 0.00% |
| Virtu Financial LLC | 13,791 | $15 | 0.00% |
| Sigma Planning Corp | 57,500 | $60,950 | 0.00% |
| VANGUARD GROUP INC | 1,080,122 | $1,144,930 | 0.00% |
| UBS Group AG | 11,243 | $11,918 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 167 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 968 | $1,354 | 0.00% |
| FMR LLC | 2 | $2 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,683 | $7,084 | 0.00% |
| WELLS FARGO & COMPANY/MN | 520 | $552 | 0.00% |
| NORTHERN TRUST CORP | 46,327 | $49,107 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 246,451 | $261 | 0.00% |
| STATE STREET CORP | 142,794 | $151,362 | 0.00% |
| Clearstead Advisors, LLC | 600 | $636 | 0.00% |
| North Star Investment Management Corp. | 250 | $265 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 36,606 | $38,802 | 0.00% |
| MORGAN STANLEY | 6,339 | $6,719 | 0.00% |
| BlackRock Inc. | 256,839 | $272,250 | 0.00% |
External links
This page lists MOLECULIN BIOTECH INC's shareholders in Q4 2022. To view MOLECULIN BIOTECH INC's shareholder history, click here.